Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03495921 |
Title | Vigil + Irinotecan and Temozolomide in Ewing's Sarcoma (VITA) |
Acronym | VITA |
Recruitment | Terminated |
Gender | both |
Phase | Phase III |
Variant Requirements | No |
Sponsors | Gradalis, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | child | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Arkansas Children's Hospital | Little Rock | Arkansas | 72202 | United States | Details | |
Southern California Permanente Medical Group | Los Angeles | California | 90027 | United States | Details | |
Mayo Clinic Florida | Jacksonville | Florida | 32224 | United States | Details | |
Nicklaus Children's Hospital | Miami | Florida | 33155 | United States | Details | |
Dana-Farber/Boston Children's Cancer and Blood Disorders | Boston | Massachusetts | 02215 | United States | Details | |
Washington University Siteman Cancer Center | Saint Louis | Missouri | 63110 | United States | Details | |
Nebraska Methodist Hospital | Omaha | Nebraska | 68114 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
Duke Children's Hospital and Health Center; Duke Cancer Institute | Durham | North Carolina | 27710 | United States | Details | |
Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | United States | Details | |
Cleveland Clinic | Cleveland | Ohio | 44195 | United States | Details | |
Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | United States | Details | |
Texas Oncology - Pediatrics | Dallas | Texas | 75230 | United States | Details | |
Cook Children's Medical Center | Fort Worth | Texas | 76104 | United States | Details | |
Seattle Cancer Care Alliance | Seattle | Washington | 98109 | United States | Details |